Alterola Biotech, Inc. Share Price Other OTC
Equities
ABTI
US02152V1035
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 35.27M 2.82B |
---|---|---|---|---|---|
Net income 2022 | -6M -480M | Net income 2023 | -1M -80.05M | EV / Sales 2022 | - |
Net Debt 2022 | 199K 15.92M | Net Debt 2023 | 1.41M 113M | EV / Sales 2023 | - |
P/E ratio 2022 |
-26.2
x | P/E ratio 2023 |
-20.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.4% |
Managers | Title | Age | Since |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 17/05/22 |
Timothy Rogers
CHM | Chairman | 60 | 20/06/21 |
Colin Stott
COO | Chief Operating Officer | 57 | 20/06/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hitchcock
CEO | Chief Executive Officer | 61 | 17/05/22 |
Nathan Thompson
BRD | Director/Board Member | - | 09/10/23 |
Daniel Reshef
BRD | Director/Board Member | 73 | - |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |